BetterLife Pharma Inc.
BETRFdata completeness 63%9 fiscal years on fileData notes: no data for concept 'revenue'; no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'
i. The business — what you’d actually own
| Figure | FY 2013 | FY 2015 | FY 2016 | FY 2017 | FY 2018 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | $341,4251 | −$1.13M2 | −$10.3M3 | −$6.28M4 | −$121,1824 |
| Operating cash flow | −$31,5865 | −$47,2576 | −$163,9427 | −$359,4498 | −$395,6028 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $4759 | $83910 | $71,63911 | $112,42111 | $64,51111 |
| Diluted shares | 35.8M | 11.6M | 77.7M | 75.6M | 82.4M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.01
your share of equity
Profit it earned you last year
−$0.01
Free cash flow it threw off
—
Debt you’d be carrying
—
10 shares is a claim on −$0.01 of net worth that earned you −$0.01 last year.
iii. Is this a good business?
Moat signal · return on equity
— avg · 5y
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Management signal · capital allocation
+130% shares · 5y
Share count is up 130% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K · period ending 2013-01-31 · accession 0001511164-13-000237 (NetIncomeLoss)
- 10-K/A · period ending 2015-01-31 · accession 0001477932-16-010741 (NetIncomeLoss)
- 10-K · period ending 2016-01-31 · accession 0001477932-17-002007 (NetIncomeLoss)
- 10-K · period ending 2017-01-31 · accession 0001477932-18-002135 (NetIncomeLoss)
- 10-K · period ending 2013-01-31 · accession 0001511164-13-000237 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2015-01-31 · accession 0001477932-16-010741 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2016-01-31 · accession 0001477932-17-002007 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2017-01-31 · accession 0001477932-18-002135 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2013-01-31 · accession 0001511164-13-000237 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2015-01-31 · accession 0001477932-17-002007 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2016-01-31 · accession 0001477932-18-002135 (CashAndCashEquivalentsAtCarryingValue)